Brand Name: Valium
Outside U.S., Brand Names also known as: Alboral; Aliseum; Alupram; Amiprol;
Anlin; Ansiolin; Antenex; Anxicalm; Anxionil; Apo-diazepam; Apozepam; Armonil;
Arzepam; Assival; Atensine; Azedipamin; Baogin; Benzopin; Best; Betapam;
Britazepam; Calmpose; Calmod; Caudel; Centrazepam; Chuansuan; Consilium;
Desconet; Desloneg; Diaceplex; Dialag; Dialar; Diapam; Diapax; Diapine; Diaquel;
Diastat; Diatran; Diazemuls; Diazepam; Diazepan; Diazepin; Dipaz; Dipezona;
Disopam; Dizam; Dizac; Doval; D-Pam; Drenian; Ducene; Dupin; Eridan; Elcion CR;
Euphorin; Euphorin P; Evacalm; Gewacalm; Gradual; Gubex; Horizon; Jinpanfan;
Kratium; Kratium 2 ; Lamra; Lembrol; Lovium; Mandro; Mandro-Zep; Melode;
Mentalium; Meval; Nellium; Nerozen; Neurosedin; Nivalen; Nixtensyn; Noan;
Notense; Novazam; Novodipam; Ortopsique; Paceum; Pacitran; Paralium; Parzam; Pax;
Paxate; Paxum; Pharmadine; Placidox 2; Placidox 5; Placidox 10; Plidan; Pomin;
Propam; Prozepam; Psychopax; Radizepam; Relanium; Reliver; Rival; Saromet;
Scriptopam; Seduxen; Servizepam; Simasedan; Sipam; Solis; Sonacon; Stesolid;
Tensium; Tranquil; Tranquirit; Trazepam; Valaxona; Valinter; Valitran;
Valrelease; Valuzepam; Vanconin; Vatran; Vazen; Vivol; Winii; Zepaxid
Valium (Diazepam) is an Anti-Anxiety medication used in the treatment of anxiety and panic attacks and as a muscle relaxant for alcohol withdrawl. Detailed info on uses, dosage and side-effects of Valium below.
Contents:
Description
Pharmacology
Indications and Usage
Contraindications
Warnings
Precautions
Drug Interactions
Adverse Reactions
Overdose
Dosage
Diazepam (Valium) is a benzodiazepine used to treat anxiety, alcohol withdrawal,
and muscle spasms. It may also be used to treat seizures, insomnia, and other
conditions as determined by your doctor. Anxiolytic, Sedative, Muscle Relaxant.
Diazepam (Valium) is a benzodiazepine with CNS depressant properties and a
somewhat flatter dose-response slope than the sedative-hypnotic drugs.
In animals, diazepam appears to act on parts of the limbic system, the thalamus
and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine
and reserpine, has no demonstrable peripheral autonomic blocking action, nor
does it produce extrapyramidal side effects; however, animals treated with
diazepam do have transient ataxia at higher doses. Diazepam was found to have
transient cardiovascular depressor effects in dogs. Long-term experiments in
rats revealed no disturbances of endocrine function. Injections into animals
have produced localized irritation of tissue surrounding injections and some
thickening of veins after intravenous use.
Peak blood levels are reached within 1-2 hours after administration.
With the parenteral form, peak blood levels are reached within 15 minutes after
i.v. administration and are of the same magnitude as after oral administration.
Diazepam (Valium) is indicated for the management of anxiety disorders or for
the short-term relief of the symptoms of anxiety. Anxiety or tension associated
with the stress of everyday life usually does not require treatment with an
anxiolytic.
In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of
acute agitation, tremor, impending or acute delirium tremens and hallucinosis.
Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to
reflex spasm to local pathology (such as inflammation of the muscles or joints,
or secondary to trauma); spasticity caused by upper motor neuron disorders (such
as cerebral palsy and paraplegia); athetosis; stiff-man syndrome; and tetanus.
The effectiveness of diazepam in long-term use, that is, more than 4 months, has
not been assessed by systematic clinical studies. The physician should
periodically reassess the usefulness of the drug for the individual patient.
Myasthenia gravis, known hypersensitivity to benzodiazepines. Not recommended
for children under 6 months of age.
It may be used in patients with open angle glaucoma who are receiving
appropriate therapy, but is contraindicated in acute narrow angle glaucoma.
Usage in Pregnancy: An increased risk of congenital malformations associated
with the use of minor tranquilizers (diazepam, meprobamate and chlordiazepoxide)
during the first trimester of pregnancy has been suggested in several studies.
Because use of these drugs is rarely a matter of urgency, their use during this
period should almost always be avoided. The possibility that a woman of
childbearing potential may become pregnant at the time of institution of therapy
should be considered. Patients should be advised that if they become pregnant
during therapy or intend to become pregnant they should communicate with their
physicians about the desirability of discontinuing the drug.
Diazepam is not of value in the treatment of psychotic patients and should not
be employed in lieu of appropriate treatment. As is true of most preparations
containing CNS-acting drugs, patients receiving diazepam should be cautioned
against engaging in hazardous occupations requiring complete mental alertness
such as operating machinery or driving a motor vehicle.
As with other agents which have anticonvulsant activity, when diazepam is used
as an adjunct in treating convulsive disorders, the possibility of an increase
in the frequency and/or severity of grand mal seizures may require an increase
in the dosage of standard anticonvulsant medication. Abrupt withdrawal of
diazepam in such cases may also be associated with a temporary increase in the
frequency and/or severity of seizures.
Since diazepam has a central nervous system depressant effect, patients should
be advised against the simultaneous ingestion of alcohol and other
CNS-depressant drugs during diazepam therapy.
Withdrawal symptoms of the barbiturate type have occurred after the
discontinuation of benzodiazepines.
If diazepam is to be combined with other psychotropic agents or anticonvulsant
drugs, careful consideration should be given to the pharmacology of the agents
to be employed - particularly with known compounds which may potentiate the
action of diazepam, such as phenothiazines, narcotics, barbiturates, MAO
inhibitors and other antidepressants. The usual precautions are indicated for
severely depressed patients or those in whom there is any evidence of latent
depression; particularly the recognition that suicidal tendencies may be present
and protective measures may be necessary. The usual precautions in treating
patients with impaired renal or hepatic function should be observed.
In elderly and debilitated patients, it is recommended that the dosage be
limited to the smallest effective amount to preclude the development of ataxia
or oversedation (2 mg to 2.5 mg once or twice daily, initially, to be increased
gradually as needed and tolerated).
Information for the Patient: To assure the safe and effective use of
benzodiazepines, patients should be informed that, since benzodiazepines may
produce psychological and physical dependence, it is advisable that they consult
with their physician before either increasing the dose or abruptly discontinuing
this drug.
Drug dependence: Abrupt cessation of large doses of diazepam after prolonged
periods may precipitate acute withdrawal symptoms and, in these cases, the drug
should be discontinued gradually. Caution should be exercised when it is
considered necessary to administer diazepam to addiction prone individuals.
Until additional information is available, injectable diazepam is not
recommended for obstetrical use.
Injectable diazepam has produced hypotension or muscular weakness in some
patients particularly when used with narcotics, barbiturates or alcohol.
Drug Interactions
If diazepam is to be combined with other psychotropic agents or anticonvulsant
drugs, careful consideration should be given to the pharmacology of the agents
to be employed - particularly with known compounds which may potentiate the
action of diazepam, such as phenothiazines, narcotics, barbiturates, MAO
inhibitors and other antidepressants. The usual precautions are indicated for
severely depressed patients or those in whom there is any evidence of latent
depression; particularly the recognition that suicidal tendencies may be present
and protective measures may be necessary. The usual precautions in treating
patients with impaired renal or hepatic function should be observed.
In elderly and debilitated patients, it is recommended that the dosage be
limited to the smallest effective amount to preclude the development of ataxia
or oversedation (2 mg to 2.5 mg once or twice daily, initially, to be increased
gradually as needed and tolerated).
The clearance of diazepam and certain other benzodiazepines can be delayed in
association with cimetidine (Tagamet) administration. The clinical significance
of this is unclear.
BEFORE USING THIS MEDICINE: INFORM YOUR DOCTOR OR
PHARMACIST of all prescription and over-the-counter medicine that you are
taking. This includes clozapine, disulfiram, lithium, omeprazole, valproic acid,
and medicines used to treat moderate to severe pain and HIV infection. Inform
your doctor of any other medical conditions, allergies, pregnancy, or
breast-feeding.
Side effects most commonly reported were drowsiness, fatigue and ataxia.
Infrequently encountered were confusion, constipation, depression, diplopia,
dysarthria, headache, hypotension, incontinence, jaundice, changes in libido,
nausea, changes in salivation, skin rash, slurred speech, tremor, urinary
retention, vertigo and blurred vision. Paradoxical reactions such as acute
hyperexcited states, anxiety, hallucinations, increased muscle spasticity,
insomnia, rage, sleep disturbances and stimulation have been reported; should
these occur, use of the drug should be discontinued.
Minor changes in EEG patterns, usually low-voltage fast activity, have been
observed in patients during and after diazepam therapy and are of no known
significance.
Because of isolated reports of neutropenia and jaundice, periodic blood counts
and liver function tests are advisable during long-term therapy.
Drug Abuse and Dependence:
Withdrawal symptoms, similar in character to those noted with barbiturates and
alcohol (convulsions, tremor, abdominal and muscle cramps, vomiting and
sweating), have occurred following abrupt discontinuance of diazepam. The more
severe withdrawal symptoms have usually been limited to those patients who had
received excessive doses over an extended period of time. Generally milder
withdrawal symptoms (e.g., dysphoria and insomnia) have been reported following
abrupt discontinuance of benzodiazepines taken continuously at therapeutic
levels for several months. Consequently, after extended therapy, abrupt
discontinuation should generally be avoided and a gradual dosage tapering
schedule followed. Addiction-prone individuals (such as drug addicts or
alcoholics) should be under careful surveillance when receiving diazepam or
other psychotropic agents because of the predisposition of such patients to
habituation and dependence.
Signs and Symptoms
Drowsiness, oversedation and ataxia. When the effects of drug overdosage begin
to wear off, the patient exhibits some jitteriness and overstimulation. The
cardinal manifestations of overdosage are drowsiness and confusion, reduced
reflexes and coma. There are minimum effects on respiration, pulse and blood
pressure unless the overdosage is extreme.
Treatment
If you or someone you know may have used more than the recommended dose of this
medicine, contact your local poison control center or emergency room
immediately.
Manifestations of diazepam overdosage include somnolence, confusion, coma and
diminished reflexes. Respiration, pulse and blood pressure should be monitored,
as in all cases of drug overdosage, although, in general, these effects have
been minimal following overdosage. General supportive measures should be
employed, along with immediate gastric lavage. Intravenous fluids should be
administered and an adequate airway maintained. Hypotension may be combated by
the use of levarterenol (Levophed) or metaraminol (Aramine). Dialysis is of
limited value. As with the management of intentional overdosage with any drug,
it should be borne in mind that multiple agents may have been ingested.
Flumazenil, a specific benzodiazepine-receptor antagonist, is indicated for the
complete or partial reversal of the sedative effects of benzodiazepines and may
be used in situations when an overdose with benzodiazepine is known or
suspected.
Do not exceed the recommended dosage or take this medicine for longer than
prescribed. Exceeding the recommended dose or taking this medicine for longer
than prescribed may be habit forming.
- Follow the directions for using this medicine provided by your doctor.
- Store this medicine at room temperature, away from heat and light.
- If you miss a dose of this medicine and you are using it regularly, take
it as soon as possible. If you do not remember until later, skip the missed
dose and go back to your regular dosing schedule. Do not take 2 doses at
once.
Additional Information: Do not share this medicine with others for
whom it was not prescribed. Do not use this medicine for other health
conditions. Keep this medicine out of the reach of children.
Dosage should be individualized for maximum beneficial effect.
Adults: Symptomatic relief of anxiety and tension in psychoneurosis
and anxiety reactions: 2 to 10 mg, 2 to 4 times daily depending upon severity of
symptoms.
Symptomatic relief in acute alcohol withdrawal: 10 mg, 3 or 4 times during
the first 24 hours, reducing to 5 mg, 3 or 4 times daily as needed.
Adjunctively for relief of skeletal muscle spasms: 2 to 10 mg, 3 to 4 times
daily.
Elderly and debilitated patients, or in the presence of debilitating
disease: 2 mg, 1 or 2 times daily initially; increase gradually as needed
and tolerated.
Children: (Because of varied responses, initiate therapy with lowest
dose and increase as required. Not for use in children under 6 months): 1 to 2.5
mg, 3 or 4 times daily initially; increase gradually as needed and tolerated.
Do not prescribe or administer diazepam for periods in excess of 6 weeks,
unless a definite need for utilizing this medication has been established by a
followup medical examination.
The information in this monograph is not intended to cover all possible uses,
directions, precautions, drug interactions or adverse effects. This information
is generalized and is not intended as specific medical advice. If you have
questions about the medicines you are taking or would like more information,
check with your doctor, pharmacist, or nurse.
top .
send to friend .
medications homepage
Reviewed: 01/2006
|